Seeking Alpha

  Navidea Biopharmaceuticals (NAVB) - NYSEMKT

  • John McCoy | Send Message 8 Mar 2013

    $NAVB moving higher approaching PDUFA date, targeting $4.50 by 4-30-13.
    Reply
      NAVB vs. ETF Alternatives
      Company Description
      Navidea Biopharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of precision diagnostics and radiopharmaceutical agent.